Juravinski Cancer Centre Foundation
13
1
1
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.5% vs industry average
15%
2 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Indocyanine Green for Detection of Sentinel Lymph Nodes In Comparison to ICG Plus Technetium in the Evaluation of Vulvar Squamous Cell Carcinoma
Role: collaborator
STereotactic Body Radiotherapy (SBRT) for Oligoprogressive Breast Cancer
Role: collaborator
Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain Relief
Role: collaborator
A Study of SBRT for Squamous Cell Carcinoma of the Head and Neck
Role: collaborator
Stereotactic Body Radiotherapy Boost After Palliative Radiotherapy for Spinal Cord Compression
Role: collaborator
Safety Study of Thioridazine in Combination With Cytarabine to Treat Relapsed or Refractory Acute Myeloid Leukemia
Role: collaborator
Feasibility Study of Stereotactic Body Radiotherapy for Early Breast Cancer
Role: collaborator
Feasibility Study of Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer: Cyberknife vs. VMAT
Role: collaborator
Sentinel Node Biopsy in Endometrial Cancer
Role: collaborator
A Prospective Study to Evaluate FDG-PET, Breast MRI, and Breast Ultrasonography in Monitoring Tumour Responses in Patients With Locally Advanced Breast Cancer (LABC) Undergoing Neoadjuvant Chemotherapy
Role: collaborator
Randomized Trial of Vaginal Self Sampling for Human Papillomavirus (HPV)
Role: collaborator
Robotic Compared to Fixed Gantry Radiosurgery for Brain Metastases
Role: collaborator
Magic Mouthwash Plus Sucralfate Versus Benzydamine Hydrochloride for the Treatment of Radiation-induced Mucositis
Role: lead
All 13 trials loaded